MarketFriction

CCME Global Ltd

BSE 514336 · Biotechnology
₹41.51 -4.99%
BSE close2026-10-01
Market cap₹208 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue from operations-0.00-0.00-0.00-0.003.67-0.00-0.00-0.00-0.00-0.000.04-0.00
Operating costs0.020.023.690.100.020.030.020.120.060.030.540.24
EBITDA-0.02-0.02-3.69-0.103.65-0.03-0.02-0.12-0.06-0.03-0.50-0.24
EBITDA margin %99.46%-1,250.00%
Depreciation & amortisation-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.02
Finance costs-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Non-operating income-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Pre-tax profit-0.02-0.02-3.69-0.103.65-0.03-0.02-0.12-0.06-0.03-0.50-0.26
Effective tax rate %-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%
Profit after tax-0.02-0.02-3.69-0.103.65-0.03-0.02-0.12-0.06-0.03-0.50-0.26
Earnings per share (Rs)-0.02-0.02-2.84-0.082.81-0.02-0.02-0.09-0.05-0.02-0.11-0.06
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue from operations-0.00-0.000.290.05-0.00-0.00-0.00-0.00-0.00-0.00-0.000.04
Operating costs0.070.070.490.100.100.120.120.143.800.170.750.87
EBITDA-0.07-0.07-0.20-0.05-0.10-0.12-0.12-0.14-3.80-0.17-0.75-0.83
EBITDA margin %-68.97%-100.00%95.37%-1,775.00%-2,075.00%
Depreciation & amortisation-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.02
Finance costs-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00
Non-operating income0.420.07-0.00-0.00-0.00-0.00-0.00-0.00-0.003.670.040.00
Pre-tax profit0.35-0.00-0.20-0.05-0.10-0.12-0.12-0.14-3.803.50-0.71-0.85
Effective tax rate %-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%
Profit after tax0.35-0.00-0.20-0.05-0.10-0.12-0.12-0.14-3.803.50-0.71-0.85
Earnings per share (Rs)0.36-0.00-0.15-0.04-0.08-0.09-0.09-0.11-2.922.69-0.16-0.24
Paid out as dividend %-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR%%%-99%
Profit CAGR%%%-124%
Share price CAGR12%43%60%-33%
Average return on equity-2%-2%-3%-3%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Net block (property, plant)-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Capital work in progress-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Investments-0.00-0.00-0.004.66-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Current & other assets4.527.106.684.869.389.329.209.098.975.218.8345.31
Total assets4.527.106.689.529.389.329.209.098.975.218.8345.31
Share capital7.129.7410.0013.0013.0013.0013.0013.0013.0013.0013.0045.25
Reserves & surplus-3.70-3.35-3.35-3.55-3.70-3.80-3.92-4.04-4.17-7.97-4.47-5.18
Total debt0.170.20-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Other liabilities & provisions0.930.510.030.070.080.120.120.130.140.180.305.24
Equity + liabilities4.527.106.689.529.389.329.209.098.975.218.8345.31
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating cash flow-4.86-2.64-0.251.68-4.690.01-0.12-0.12-0.09-0.00-0.005.10
Investing cash flow0.77-0.00-0.00-4.664.66-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Free cash flow (after capex)-4.09-2.64-0.251.68-4.690.01-0.12-0.12-0.09-0.00-0.005.10
Financing cash flow4.102.620.263.00-0.00-0.000.120.120.09-0.00-0.0032.25
Net change in cash0.01-0.020.010.02-0.030.01-0.00-0.00-0.01-0.00-0.0037.35
Cash conversion (OCF / EBITDA) %3,240%3,771%357%-840%9,380%-10%100%100%64%-0%-0%-680%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Return on capital employed %-16.62%6.88%-0.00%-2.48%-0.53%-1.08%-1.31%-1.33%-1.57%-54.83%51.62%-2.92%
Receivable days229.2962.93292.00
Inventory days-0.00-0.00
Payable days
Cash cycle (days)229.2962.93292.00
Working capital days1,586.355,991.0367,890.00
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter group %11.33%11.33%11.33%11.33%11.33%11.33%11.33%11.33%11.33%11.33%74.17%74.35%
Retail & others %88.68%88.68%88.68%88.68%88.68%88.68%88.68%88.68%88.68%88.68%25.83%25.65%
Shareholder count1,7451,7521,7491,7501,7511,7511,7471,7311,7361,8551,9381,937

Fundamentals

Market value₹ 208 Cr.
Last price₹ 46.0
Book value / share₹ 8.86
Return on capital-2.92 %
Return on equity-2.92 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-99%
Profit CAGR (TTM)-124%
Standalone figures.
Valuation
Market capRs 188 Cr
Enterprise valueRs 150 Cr
Price to book4.69x
Price to cash flow36.83x
Earnings yield-0.45%
P/E, 3-year average6.81x
P/B, 3-year average5.78x
P/E, 5-year average6.81x
P/B, 5-year average4.06x
Profitability
ROE-2.92%
ROCE-2.92%
ROA-2.62%
ROE, 3-year average-2.04%
ROCE, 3-year average-2.04%
ROA, 3-year average-2.12%
ROE, 5-year average-1.81%
ROCE, 5-year average-1.81%
ROA, 5-year average-1.84%
ROIC (approx.)-31.37%
Other income / net worth0.10%
Growth
Profit growth (latest year)-120.29%
Per share
EPS (TTM)Rs -0.19
EPS (latest year)Rs -0.16
EPS (latest quarter)Rs -0.06
EPS, 3-year averageRs -0.13
EPS, 5-year averageRs -0.12
Book value per shareRs 8.86
Cash flow per shareRs 1.13
Leverage
Cash and bankRs 37 Cr
Net debtRs -37 Cr
Owners' fund to total sources88.44%
Cash flow
Operating cash flow (latest year)Rs 5 Cr
Financing cash flow (latest year)Rs 32 Cr
Net change in cash (latest year)Rs 37 Cr
Statement figures
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -1 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -1 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 45 Cr
ReservesRs -5 Cr
Shareholders' fundsRs 40 Cr
Total assetsRs 45 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)4.53
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 4.69 is at the 36th percentile (median 5.29).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period514336Nifty 50Difference
1 week-5.4%-2.8% -2.7 pts
1 month-0.7%-6.8% +6.1 pts
3 months-67.1%-7.6% -59.4 pts
3 years+269.3%+14.2% +255.1 pts
5 years+431.5%+27.9% +403.6 pts

Red flags

F-score 3 of 6
explainShare dilution Share count up 248% in a year, 248% in three
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Anthem Biosciences Ltd48,99682.630.4 %
Advanced Enzyme Technologies Ltd3,15220.014.0 %
Vivo Bio Tech Ltd367.74 %
Shree Ganesh Biotech India Ltd191.31 %
Genomic Valley Biotech Ltd98861.02 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of CCME Global Ltd?

CCME Global Ltd (514336) has a market capitalisation of Rs 208 Cr. at the 2026-10-01 close.

What were CCME Global Ltd's latest quarterly results?

In the Jun 2026 quarter, CCME Global Ltd sales was Rs 0 Cr with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03